Diabetic amyotrophy is a disabling illness that is distinct from other
forms of diabetic neuropathy, It is characterized by weakness followe
d by wasting of pelvifemoral muscles, either unilaterally or bilateral
ly, with associated pain, Sensory impairment is minimal in the cutaneo
us distribution sharing the same root or peripheral nerve as affected
musculature. Most commonly, the onset is in middle age or later, altho
ugh it may occur in youth, A concomitant distal predominantly sensory
neuropathy may be present, Electrodiagnostic studies are most often co
nsistent with a neurogenic lesion attributable to a lumbosacral radicu
lopathy, plexopathy, or proximal crural neuropathy. The natural course
of the illness is variable with gradual but often incomplete improvem
ent, The site of the lesion and the pathogenesis of diabetic amyotroph
y remain controversial, Recent studies suggest a role for immunomodula
ting agents in certain types of diabetic neuropathy, including diabeti
c amyotrophy.